Cidara Therapeutics Inc
F:20D0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cidara Therapeutics Inc
F:20D0
|
US |
|
Vinci SA
PAR:DG
|
FR |
|
P
|
Poly Property Group Co Ltd
OTC:PHKIF
|
HK |
|
Almirall SA
MAD:ALM
|
ES |
|
A
|
ANI Pharmaceuticals Inc
SWB:BSFA
|
US |
|
Aena SME SA
F:A441
|
ES |
|
Realty Income Corp
NYSE:O
|
US |
|
PDD Holdings Inc
NASDAQ:PDD
|
CN |
|
I
|
ideaForge Technology Ltd
NSE:IDEAFORGE
|
IN |
|
ABO Energy GmbH & Co KgaA
F:AB9
|
DE |
|
Generation Mining Ltd
TSX:GENM
|
CA |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
US |
|
Arcosa Inc
NYSE:ACA
|
US |
|
Netflix Inc
NASDAQ:NFLX
|
US |
|
C
|
Compagnie de Saint Gobain SA
XMUN:GOB
|
FR |
|
A
|
ANI Pharmaceuticals Inc
F:BSFA
|
US |
|
Nanto Bank Ltd
TSE:8367
|
JP |
|
Logitech international SA
F:LTEC
|
CH |
|
Kawasaki Heavy Industries Ltd
F:KHE
|
JP |
|
Safestay PLC
LSE:SSTY
|
UK |
|
Grail Inc
F:NL0
|
US |
|
E
|
Enterprise Metals Ltd
ASX:ENT
|
AU |
|
Nomura Research Institute Ltd
F:NR7
|
JP |
|
IPH Ltd
F:1IP
|
AU |
Bankruptcy Probability
Cidara Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cidara Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Cidara Therapeutics Inc
F:20D0
|
5.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
505.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
207.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
103.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
91.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
55.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cidara Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cidara Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
